There are methodological differences between the use of different drugs in animal models of atherosclerosis that may contribute to discrepancies in research findings related to the role of DEL-1 in atherosclerosis (Kakino et al., 2016; Emini Veseli et al., 2017). The gene discussed is EDIL3; the disease is atherosclerosis.